The multi-billion-dollar BioPharma industry is undergoing more change than ever before. The impending presidential election, ever escalating innovations in tech and AI, new drug legislation, and inflation all have an impact and it’s extremely challenging to predict the net effect.
In our latest industry insight report, we investigate broader industry trends and also delve into talent insights for Massachusetts; the state that continues to be a beacon of innovation and growth.
